Alamar Biosciences, Inc. (ALMR) Q3 2026 earnings results
Alamar Biosciences, Inc. (ALMR) reported Q3 2026 results on Nov 3, 2026, 4:10:15 PM ET: GAAP EPS -$0.19, in line with the estimate; revenue $33.55M vs. $30.19M expected (beat by 11.1%). Outlook: Full-year 2026 revenue guidance raised to $121 million to $123 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | -$0.19 | -$0.19 | In line |
| Revenue | $33.55M | $30.19M | Beat by 11.1% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 3, 2026, 4:10:15 PM ET. Nexqual published them 48 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 68.5% from $19.91M; GAAP diluted EPS was -$0.19 vs. -$0.69 (+72.5%).
Stock reaction
The results came out after the market closed. ALMR closed at $27.39 on November 4, 2026, down 9.4% from its $30.22 close on November 3, 2026 before the results. Latest: $31.60 as of 11:53 AM ET, +4.6% since the pre-release close.
Questions and answers
Did Alamar Biosciences, Inc. beat earnings expectations?
In line. Alamar Biosciences, Inc. reported GAAP EPS of -$0.19 against an average analyst estimate of -$0.19, and revenue of $33.55M against $30.19M expected (beat by 11.1%).
What were Alamar Biosciences, Inc.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of -$0.19 and revenue of $33.55M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 68.5% from $19.91M; GAAP diluted EPS was -$0.19 vs. -$0.69 (+72.5%).
When did Alamar Biosciences, Inc. report Q3 2026 earnings?
Nov 3, 2026, 4:10:15 PM ET, in an SEC 8-K filing (Item 2.02).
How did ALMR stock react to the earnings?
The results came out after the market closed. ALMR closed at $27.39 on November 4, 2026, down 9.4% from its $30.22 close on November 3, 2026 before the results. Latest: $31.60 as of 11:53 AM ET, +4.6% since the pre-release close.
What did Alamar Biosciences, Inc. say about its outlook?
Full-year 2026 revenue guidance raised to $121 million to $123 million.
More on ALMR
ALMR stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 3, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt